36646 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 16
00:12 UTC
|
ENB
Enbridge
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Outperform | C$81.00→ C$82.00+1.2% |
|
Sep 16
00:12 UTC
|
ENB
Enbridge
|
↑ Upgrade | firm only | Market Perform→ Outperform | C$79.00→ C$79.50+0.6% |
|
Sep 16
00:12 UTC
|
ENB
Enbridge
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Outperform | |
|
Sep 16
00:12 UTC
|
CRDF
Cardiff Oncology
|
↑ Upgrade | Robert Burns ★★☆☆☆ #2846 | Neutral→ Buy | |
|
Sep 16
00:12 UTC
|
CFP
Canfor
|
↑ Upgrade | firm only | Outperform→ Strong-Buy | C$17.00→ C$21.00+23.5% |
|
Sep 16
00:12 UTC
|
BNTC
Benitec Biopharma
|
↑ Upgrade | firm only | Outperform | |
|
Sep 16
00:12 UTC
|
AZN
Astrazeneca
|
↑ Upgrade | firm only | Sell→ Hold | |
|
Sep 16
00:12 UTC
|
AGL
Agilon Health
|
↑ Upgrade | Lance Wilkes ★★★☆☆ #1177 | Market Perform→ Outperform | $86.00→ $125.00+45.3% |
|
Sep 16
00:12 UTC
|
ADNT
Adient
|
↑ Upgrade | Rajat Gupta not yet tracked | Neutral→ Overweight | $28.00→ $25.00-10.7% |
|
Sep 15
23:12 UTC
|
BAK
Braskem
|
↓ Downgrade | firm only | Neutral→ Sell | $1.50 |
|
Sep 15
22:12 UTC
|
BAK
Braskem
|
↓ Downgrade | firm only | Neutral→ Sell | |
|
Sep 15
22:12 UTC
|
REXR
Rexford Industrial Realty
|
↑ Upgrade | David Rodgers not yet tracked | Underperform→ Market Perform | |
|
Sep 15
21:11 UTC
|
INTC
Intel
|
◎ Target | Ivan Feinseth ★★☆☆☆ #2716 | Buy | $118.00→ $145.00+22.9% |
|
Sep 15
19:20 UTC
|
MTY
MTY Food Group
|
◎ Target | firm only | Outperform | C$43.00→ C$40.00-7.0% |
|
Sep 15
19:20 UTC
|
ET
Evertz Technologies
|
◎ Target | firm only | Sec→ r Perform | C$17.00→ C$16.00-5.9% |
|
Sep 15
19:20 UTC
|
ET
Evertz Technologies
|
◎ Target | firm only | Outperform | C$18.00→ C$16.50-8.3% |
|
Sep 15
19:20 UTC
|
ET
Evertz Technologies
|
◎ Target | firm only | Outperform | C$18.00→ C$17.00-5.6% |
|
Sep 15
19:20 UTC
|
ENB
Enbridge
|
◎ Target | firm only | Outperform | C$83.00→ C$84.00+1.2% |
|
Sep 15
19:20 UTC
|
ENB
Enbridge
|
◎ Target | firm only | Market Perform | C$79.00→ C$80.00+1.3% |
|
Sep 15
19:20 UTC
|
CGX
Cineplex
|
◎ Target | firm only | Outperform | C$14.00→ C$15.00+7.1% |
|
Sep 15
19:20 UTC
|
BCE
BCE
|
◎ Target | firm only | Buy | C$37.00→ C$40.00+8.1% |
|
Sep 15
19:20 UTC
|
AGF.B
AGF Management
|
◎ Target | firm only | Buy | C$24.00→ C$23.00-4.2% |
|
Sep 15
19:20 UTC
|
ET
Evertz Technologies
|
↓ Downgrade | firm only | Buy→ Hold | C$18.00→ C$15.00-16.7% |
|
Sep 15
19:20 UTC
|
TRP
TC Energy
|
↑ Upgrade | firm only | Hold→ Buy | C$102.00 |
|
Sep 15
19:20 UTC
|
QBR.B
Quebecor
|
↑ Upgrade | firm only | Market Perform→ Outperform | C$72.00→ C$75.00+4.2% |
|
Sep 15
19:20 UTC
|
IFP
Interfor
|
↑ Upgrade | firm only | Outperform→ Strong-Buy | C$17.00→ C$21.00+23.5% |
|
Sep 15
19:20 UTC
|
ENB
Enbridge
|
↑ Upgrade | firm only | Hold→ Buy | C$82.00→ C$81.00-1.2% |
|
Sep 15
19:20 UTC
|
ENB
Enbridge
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Outperform | C$81.00→ C$82.00+1.2% |
|
Sep 15
19:20 UTC
|
ENB
Enbridge
|
↑ Upgrade | firm only | Market Perform→ Outperform | C$79.00→ C$79.50+0.6% |
|
Sep 15
19:20 UTC
|
CFP
Canfor
|
↑ Upgrade | firm only | Outperform→ Strong-Buy | C$17.00→ C$21.00+23.5% |
|
Sep 15
18:19 UTC
|
ELF
e.l.f. Beauty
|
◎ Target | Anna Lizzul ★★★☆☆ #1069 | Buy | $100.00→ $118.00+18.0% |
|
Sep 15
18:19 UTC
|
CSHR
CoinShares
|
◎ Target | Alex Bond ★★★☆☆ #1975 | Outperform | $7.00→ $9.00+28.6% |
|
Sep 15
18:19 UTC
|
CCL
Carnival
|
◎ Target | Chris Woronka ★★★☆☆ #1170 | Hold | $34.00→ $29.00-14.7% |
|
Sep 15
18:19 UTC
|
BBNX
Beta Bionics
|
◎ Target | Travis Steed ★★★★☆ #939 | Neutral | $18.00→ $20.00+11.1% |
|
Sep 15
17:19 UTC
|
RFIL
RF Industries
|
◎ Target | Tyler Burmeister ★★☆☆☆ #2744 | Buy | $19.00→ $17.00-10.5% |
|
Sep 15
17:19 UTC
|
RFIL
RF Industries
|
◎ Target | Josh Nichols ★★★☆☆ #1585 | Buy | $15.00→ $12.00-20.0% |
|
Sep 15
17:19 UTC
|
RBLX
Roblox
|
◎ Target | Eric Handler ★★★★☆ #787 | Buy | $55.00→ $60.00+9.1% |
|
Sep 15
17:19 UTC
|
PAYS
Paysign
|
◎ Target | Jacob Stephan ★★★☆☆ #1923 | Buy | $13.00→ $15.00+15.4% |
|
Sep 15
17:19 UTC
|
FTI
TechnipFMC
|
◎ Target | Scott Gruber ★★★☆☆ #2059 | Buy | $80.00→ $85.00+6.2% |
|
Sep 15
17:19 UTC
|
CHYM
Chime Financial
|
◎ Target | Will Nance ★★★☆☆ #1756 | Buy | $33.00→ $37.00+12.1% |
|
Sep 15
17:19 UTC
|
ABOS
Acumen Pharmaceuticals
|
◎ Target | Geoff Meacham ★★★☆☆ #1641 | Buy | $4.00→ $5.00+25.0% |
|
Sep 15
17:19 UTC
|
SEIC
SEI Investments
|
↑ Upgrade | Jeff Schmitt ★★★☆☆ #1343 | Market Perform→ Outperform | |
|
Sep 15
16:19 UTC
|
VNO
Vornado Realty Trust
|
◎ Target | Anthony Paolone ★★★☆☆ #1778 | Neutral | $37.00→ $39.00+5.4% |
|
Sep 15
16:19 UTC
|
VICI
VICI Properties
|
◎ Target | Ronald Kamdem ★★★☆☆ #2005 | Equal Weight | $31.00→ $29.00-6.5% |
|
Sep 15
16:19 UTC
|
VC
Visteon
|
◎ Target | Rajat Gupta not yet tracked | Overweight | $170.00→ $145.00-14.7% |
|
Sep 15
16:19 UTC
|
SRRK
Scholar Rock
|
◎ Target | Allison Bratzel ★★★☆☆ #2123 | Overweight | $60.00→ $75.00+25.0% |
|
Sep 15
16:19 UTC
|
SNX
TD SYNNEX
|
◎ Target | Erik Woodring ★★★☆☆ #1183 | Overweight | $374.00→ $334.00-10.7% |
|
Sep 15
16:19 UTC
|
OBIO
Orchestra BioMed
|
◎ Target | Madison El-Saadi not yet tracked | Buy | $10.00→ $11.00+10.0% |
|
Sep 15
16:19 UTC
|
GTX
Garrett Motion
|
◎ Target | Rajat Gupta not yet tracked | Overweight | $37.00→ $35.00-5.4% |
|
Sep 15
16:19 UTC
|
FTK
Flotek Industries
|
◎ Target | Robert Brown ★☆☆☆☆ #2912 | Buy | $40.00→ $44.00+10.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.